CoQ10 may interact with certain medications, causing side effects or making them less effective. Find out if you shouldn't ...

Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.

Key Takeaways Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and ...

Network meta-analysis found modest short-term effects of stimulants and selective noradrenaline reuptake inhibitors alike with regard to systolic blood pressure, diastolic blood pressure, and ...

Similarly, propranolol, as a noradrenaline inhibitor, shows certain potential. However, current research on its use for PTSD treatment remains in its early stages.

The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with inhibitors by preventing or reducing bleeding episodes in adults and children ...

Non-selective beta blockers – such as propranolol block adrenaline and noradrenaline act in other areas of the body as well as the heart. This is why they’re more commonly used to treat non-heart ...

The full potential for anti-PD-1 checkpoint inhibitors remains untapped. Investigational inhibitors will continue gaining approval and expanding this inhibitor mechanism's applicability.

Physician understanding about the safety and efficacy of Janus kinase inhibitors for patients with rheumatoid arthritis has evolved with real-world and clinical trial data.

Stimulants are first-line drugs for attention-deficit hyperactivity disorder. But how do they actually work?

The use of poly (ADP-ribose) polymerase (PARP) inhibitor therapy is standard care in the management of patients with various malignancies including ovarian, breast, prostate, and pancreatic cancers.

Dr Matthew Smith discusses next generation androgen receptor inhibitors and data from clinical trials with these agents.